THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER (EIN 472364652) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

DR INDERPAL RANDHAWA

Phone

5624909900

Tax Period

2023-01-01 to 2023-12-31

THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER, founded in 2014, is a mid-sized nonprofit in the Health Care sector that reported $10.6M in total revenue in fiscal year 2023. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $9.6M left a modest 9% surplus.

Mission

TO CREATE THE UNIQUE OPPORTUNITY FOR SPECIALISTS WITHIN THE RARE DISEASE COMMUNITY, INCLUDING CLINICAL PHYSICIAN RESEARCHERS, SCIENTISTS AND ADVOCATES, TO WORK IN A SINGLE COLLABORATIVE AND MORE EFFICIENT ENVIRONMENT. THE ORGANIZATION WILL FOCUS ON FIVE MEDICAL CONDITIONS: ADULT CYSTIC FIBROSIS, FOOD ALLERGY AND INTOLERANCE, BRONCHIECTASIS, IMMUNE DEFICIENCY AND AIREWAY INFLAMMATORY DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $727,019

Program Service Revenue $8,842,056

Investment Income $43

Other Revenue $1,000,000

TOTAL REVENUE $10,569,118

Expense Breakdown

Grants Paid $0

Salaries & Benefits $2,459,351

Fundraising Expenses $323,827

Program Expenses $7,431,378

Other Expenses $7,168,623

TOTAL EXPENSES $9,627,974

Year-over-Year Comparison

	2023	2022	Change
Revenue	$10,569,118	$13,971,244	-0.2%
Expenses	$9,627,974	$12,569,336	-0.2%
Net Income	$941,144	$1,401,908	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$369,335

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NATHAN MARSTELLER	DOR-DIRECTOR,RESEARCH	40.00	Director	$178,618	$3,171	$181,789
DELMY SEVILLA	DIRECTOR,BILLING OPERATIONS	40.00	Director	$180,772	$1,774	$182,546
JIM MCDONNELL	BOARD MEMBER	5.00	Director	$5,000	$0	$5,000
PALMA GALLAGOS	BOARD MEMBER	5.00	Director	$0	$0	$0
JEFF SHAPACK	BOARD MEMBER	5.00	Director	$0	$0	$0
PAUL ORLIN	BOARD MEMBER	5.00	Director	$0	$0	$0
HALEIGH RAFF	BOARD MEMBER	5.00	Director	$0	$0	$0
PETER NGO	LABATORY MANAGER	40.00	Highest	$145,698	$0	$145,698
LIDA MOHTASHAM	PHYSICIAN	40.00	Highest	$191,615	$0	$191,615
BUGSU OVUNC	PHYSICIAN	40.00	Highest	$246,751	$0	$246,751
PRIYANKA VAKATI	PHYSICIAN	40.00	Highest	$234,645	$2,982	$237,627
HAO BLAIR ZHANG	PROJECT MANAGER	40.00	Highest	$144,650	$10,117	$154,767

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$10,569,118	$9,627,974	$6,154,954	$941,144
2022	$13,971,244	$12,569,336	$5,168,526	$1,401,908
2021	$21,502,717	$19,981,851	$5,349,856	$1,520,866
2020	$15,185,212	$17,145,022	$2,775,289	$-1,959,810
2019	$8,634,137	$8,521,648	$2,773,404	$112,489
2018	$3,309,218	$3,025,874	$2,082,992	$283,344

THE TRANSLATIONAL PULMONARY AND IMMUNOLOGY RESEARCH CENTER